skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,816  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Material Type:
Article
Add to My Research

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Cell, 2021-01, Vol.184 (1), p.64-75.e11 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Author(s) 2020 ;ISSN: 0092-8674 ;ISSN: 1097-4172 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.11.020 ;PMID: 33275900

Digital Resources/Online E-Resources

2
Seasonal coronavirus protective immunity is short-lasting
Material Type:
Article
Add to My Research

Seasonal coronavirus protective immunity is short-lasting

Nature medicine, 2020-11, Vol.26 (11), p.1691-1693 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;ISSN: 1546-170X ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-1083-1 ;PMID: 32929268

Full text available

3
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Material Type:
Article
Add to My Research

Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas

The American journal of pathology, 2022-04, Vol.192 (4), p.642-652 [Peer Reviewed Journal]

2022 American Society for Investigative Pathology ;Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. ;2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. 2022 American Society for Investigative Pathology ;ISSN: 0002-9440 ;EISSN: 1525-2191 ;DOI: 10.1016/j.ajpath.2022.01.007 ;PMID: 35123975

Full text available

4
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
Material Type:
Article
Add to My Research

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

Science (American Association for the Advancement of Science), 2021-10, Vol.374 (6566), p.423-431 [Peer Reviewed Journal]

Attribution ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abj4336 ;PMID: 34672751

Digital Resources/Online E-Resources

5
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Material Type:
Article
Add to My Research

Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e1128-e1136 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab721 ;PMID: 34423834

Full text available

6
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update
Material Type:
Article
Add to My Research

The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update

Nucleic acids research, 2022-07, Vol.50 (W1), p.W345-W351 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research. ;info:eu-repo/semantics/openAccess ;Attribution ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkac247 ;PMID: 35446428

Full text available

7
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells
Material Type:
Article
Add to My Research

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

PLoS pathogens, 2021-01, Vol.17 (1), p.e1009233-e1009233 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;2021 Sasaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Sasaki et al 2021 Sasaki et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1009233 ;PMID: 33476327

Full text available

8
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Material Type:
Article
Add to My Research

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

New England Journal of Medicine, 2022-04, Vol.386 (16), p.1532-1546 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2119451 ;PMID: 35249272

Digital Resources/Online E-Resources

9
UniProt: the universal protein knowledgebase in 2021
Material Type:
Article
Add to My Research

UniProt: the universal protein knowledgebase in 2021

Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D480-D489 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2021 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa1100 ;PMID: 33237286

Digital Resources/Online E-Resources

10
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
Material Type:
Article
Add to My Research

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission

Cell host & microbe, 2022-03, Vol.30 (3), p.373-387.e7 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2022.01.006 ;PMID: 35150638

Full text available

11
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Material Type:
Article
Add to My Research

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Cell, 2021-04, Vol.184 (9), p.2372-2383.e9 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.013 ;PMID: 33743213

Full text available

12
Ensembl 2021
Material Type:
Article
Add to My Research

Ensembl 2021

Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D884-D891 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2021 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa942 ;PMID: 33137190

Digital Resources/Online E-Resources

13
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Material Type:
Article
Add to My Research

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Nature (London), 2022-04, Vol.604 (7906), p.553-556 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Apr 21, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04594-4 ;PMID: 35240676

Full text available

14
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Material Type:
Article
Add to My Research

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Nature reviews. Microbiology, 2023-03, Vol.21 (3), p.162-177 [Peer Reviewed Journal]

2023. Springer Nature Limited. ;Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;Springer Nature Limited 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/s41579-022-00841-7 ;PMID: 36653446

Full text available

15
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Material Type:
Article
Add to My Research

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Cell, 2022-07, Vol.185 (14), p.2422-2433.e13 [Peer Reviewed Journal]

2022 ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.06.005 ;PMID: 35772405

Digital Resources/Online E-Resources

16
SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects - correspondence
Material Type:
Article
Add to My Research

SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects - correspondence

International journal of surgery (London, England), 2023-04, Vol.109 (4), p.1054-1055 [Peer Reviewed Journal]

2023 the Author(s). Published by Wolters Kluwer Health, Inc. 2023 ;ISSN: 1743-9159 ;EISSN: 1743-9159 ;DOI: 10.1097/JS9.0000000000000276 ;PMID: 36912769

Full text available

17
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Material Type:
Article
Add to My Research

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis

The Lancet. Microbe, 2022-01, Vol.3 (1), p.e52-e61 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2022 ;ISSN: 2666-5247 ;EISSN: 2666-5247 ;DOI: 10.1016/S2666-5247(21)00267-6 ;PMID: 34806056

Full text available

18
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Material Type:
Article
Add to My Research

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Cell, 2023-01, Vol.186 (2), p.279-286.e8 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.12.018 ;PMID: 36580913

Full text available

19
SARS-CoV-2 viral load and shedding kinetics
Material Type:
Article
Add to My Research

SARS-CoV-2 viral load and shedding kinetics

Nature reviews. Microbiology, 2023-03, Vol.21 (3), p.147-161 [Peer Reviewed Journal]

2022. Springer Nature Limited. ;Springer Nature Limited 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/s41579-022-00822-w ;PMID: 36460930

Full text available

20
The UCSC Genome Browser database: 2022 update
Material Type:
Article
Add to My Research

The UCSC Genome Browser database: 2022 update

Nucleic acids research, 2022-01, Vol.50 (D1), p.D1115-D1122 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. 2022 ;The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkab959 ;PMID: 34718705

Full text available

Results 1 - 20 of 5,816  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,742)

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (447)
  3. 2021 To 2021  (1,829)
  4. 2022 To 2023  (3,052)
  5. After 2023  (488)
  6. More options open sub menu

Resource Type 

  1. Articles  (5,815)
  2. magazinearticle  (1)
  3. More options open sub menu

Language 

  1. English  (5,809)
  2. Japanese  (628)
  3. Portuguese  (15)
  4. Norwegian  (10)
  5. Spanish  (8)
  6. Russian  (4)
  7. French  (3)
  8. Chinese  (2)
  9. More options open sub menu

Searching Remote Databases, Please Wait